Why the study?
Long-term comparative outcomes between porcine and pericardial bioprostheses for SAVR remain debated, with scarce direct comparative data among contemporary devices.
Do porcine bioprostheses improve long-term freedom from structural valve deterioration compared to pericardial bioprostheses in patients undergoing surgical aortic valve replacement?
Do porcine bioprostheses improve long-term freedom from structural valve deterioration compared to pericardial bioprostheses in patients undergoing surgical aortic valve replacement?
In patients undergoing surgical aortic valve replacement, porcine bioprostheses demonstrated better long-term protection from structural valve deterioration at 10 years compared to pericardial valves, despite a higher risk of patient-prosthesis mismatch.
Answers are grounded in this paper and cite their sources.
Porcine bioprostheses were associated with lower 10-year SVD rates; this Level 3 finding leaves open need for RCTs before changing valve selection.
The long-term comparative results between porcine and pericardial bioprostheses for surgical aortic valve replacement (SAVR) are debated. Scarce information exists concerning direct comparative evaluation among contemporary devices. We compared late and very late results in a single center series (n = 3,983 cases). From a prospectively collected database we included 3,983 recipients of two current porcine bioprostheses (porcine group) or one current pericardial bioprosthesis (pericardial group). We evaluated the long-term freedom from structural valve deterioration (SVD) with both Kaplan–Meier and competing risk methods (primary endpoint). We distinguished between SVD and patient-prosthesis mismatch (PPM). Secondary endpoints were late survival, freedom from valve-related mortality, freedom from reoperation for SVD, freedom from nonstructural valve dysfunction (NSVD) and freedom from endocarditis. Median follow-up was 10.4 years (99.7% complete, 32,219 patients/years). Overall survival was significantly lower in the porcine group (p = 0.002), related to baseline intergroup differences. At 10 years, Kaplan–Meier freedom from SVD was significantly better in the porcine group (98.0% ± 0.3 vs. 96.3% ± 0.8; p = 0.003). Competing risk freedom from SVD at 10 years was 98.6% ± 0.2 and 97.2% ± 0.6 (porcine and pericardial group, respectively; p = 0.001). The porcine group displayed a higher rate of PPM. Despite the augmented risk of PPM compared with pericardial valves, in this series porcine bioprostheses seem to perform better concerning protection from late (>10 years) SVD. Smaller valve sizes (19–21 mm) may negatively impact the SVD risk among porcine valves but not among pericardial valves. These elements need to be considered for valve choice and surgical strategy in SAVR candidates according to their life expectancy, clinical context, and annulus size.
No takes yet. Share an insight, caveat, or question.
Anselmi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: